Prenetics Global Ltd (NASDAQ:PRE) — Market Cap & Net Worth
Market Cap & Net Worth: Prenetics Global Ltd (PRE)
Prenetics Global Ltd (NASDAQ:PRE) has a market capitalization of $284.21 Million ($284.21 Million) as of August 1, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #14975 globally and #3528 in its home market, demonstrating a -4.02% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Prenetics Global Ltd's stock price $18.64 by its total outstanding shares 15247465 (15.25 Million). See Prenetics Global Ltd capex to cash flow ratio to understand how much of operating cash flow is reinvested back into capital assets.
Prenetics Global Ltd Market Cap History: 2021 to 2026
Prenetics Global Ltd's market capitalization history from 2021 to 2026. Data shows change from $1.76 Billion to $284.21 Million (-30.48% CAGR).
Index Memberships
Prenetics Global Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.46 Trillion | 0.01% | #407 of 976 |
|
NASDAQ Composite
IXIC
|
$40.26 Trillion | 0.00% | #1461 of 3165 |
Weight: Prenetics Global Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Prenetics Global Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Prenetics Global Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.89x
Prenetics Global Ltd's market cap is 2.89 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $1.76 Billion | $12.53 Million | -$174.01 Million | 140.05x | N/A |
| 2022 | $457.42 Million | $13.16 Million | -$190.45 Million | 34.75x | N/A |
| 2023 | $90.11 Million | $21.74 Million | -$62.72 Million | 4.14x | N/A |
| 2024 | $88.44 Million | $30.62 Million | -$46.30 Million | 2.89x | N/A |
Competitor Companies of PRE by Market Capitalization
Companies near Prenetics Global Ltd in the global market cap rankings as of August 1, 2026.
Key companies related to Prenetics Global Ltd by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $215.77 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #169 globally with a market cap of $137.72 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #577 globally with a market cap of $46.48 Billion USD ( CN¥317.64 Billion CNY).
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #616 globally with a market cap of $43.83 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $215.77 Billion | $574.30 |
| #169 | Danaher Corporation | NYSE:DHR | $137.72 Billion | $194.98 |
| #577 | WuXi AppTec Co Ltd | SHG:603259 | $46.48 Billion | CN¥128.43 |
| #616 | IDEXX Laboratories Inc | NASDAQ:IDXX | $43.83 Billion | $559.07 |
Prenetics Global Ltd Historical Marketcap From 2021 to 2026
Between 2021 and today, Prenetics Global Ltd's market cap moved from $1.76 Billion to $ 284.21 Million, with a yearly change of -30.48%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $284.21 Million | +18.35% |
| 2025 | $240.15 Million | +171.55% |
| 2024 | $88.44 Million | -1.86% |
| 2023 | $90.11 Million | -80.30% |
| 2022 | $457.42 Million | -73.94% |
| 2021 | $1.76 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of Prenetics Global Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $284.21 Million USD |
| MoneyControl | $284.21 Million USD |
| MarketWatch | $284.21 Million USD |
| marketcap.company | $284.21 Million USD |
| Reuters | $284.21 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Prenetics Global Ltd
Prenetics Global Limited, a health sciences company, focuses on advancing consumer health in Hong Kong, the United States, and internationally. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand. The company is also involved in the operation of CircleDNA, a consumer genetic testing… Read more